$113 B

MDT Mkt cap, 18-Apr-2019

$7.5 B

Medtronic Revenue Q3, 2019
Medtronic Gross profit (Q3, 2019)5.3 B
Medtronic Gross profit margin (Q3, 2019), %70%
Medtronic Net income (Q3, 2019)1.3 B
Medtronic EBIT (Q3, 2019)1.5 B
Medtronic Cash, 25-Jan-20193.7 B
Medtronic EV134.3 B

Medtronic Revenue

Medtronic revenue was $29.95 b in FY, 2018 which is a 0.8% year over year increase from the previous period.

Embed Graph

Medtronic Revenue Breakdown

Embed Graph

Medtronic revenue breakdown by business segment: 7.1% from Diabetes Group, 25.9% from Restorative Therapies Group, 37.9% from Cardiac and Vascular Group and 29.1% from Minimally Invasive Therapies Group

Medtronic revenue breakdown by geographic segment: 46.7% from Rest of World, 53.0% from United States and 0.3% from Other

Medtronic Income Statement

Annual

USDFY, 2016FY, 2017FY, 2018

Revenue

28.8b29.7b30.0b

Revenue growth, %

42%3%1%

Cost of goods sold

9.1b9.3b9.1b

Gross profit

19.7b20.4b20.9b

Gross profit Margin, %

68%69%70%

R&D expense

2.2b2.2b2.3b

General and administrative expense

9.5b9.7b10.0b

Operating expense total

12.4b13.1b12.4b

Depreciation and amortization

1.9b2.0b1.8b

EBIT

5.4b5.3b6.7b

EBIT margin, %

19%18%22%

Interest expense

1.4b1.1b1.1b

Interest income

431.0m366.0m397.0m

Pre tax profit

4.3b4.6b5.7b

Income tax expense

798.0m578.0m2.6b

Net Income

3.5b4.0b3.1b

Medtronic Balance Sheet

Annual

USDFY, 2016FY, 2017FY, 2018

Cash

2.9b5.0b3.7b

Accounts Receivable

5.6b5.6b6.0b

Inventories

3.5b3.3b3.6b

Current Assets

23.6b24.9b23.0b

PP&E

4.8b4.4b4.6b

Goodwill

41.5b38.5b39.5b

Total Assets

99.6b99.8b91.4b

Accounts Payable

1.7b1.6b1.6b

Short-term debt

993.0m7.5b2.1b

Current Liabilities

7.2b14.3b10.1b

Long-term debt

30.1b25.9b23.7b

Total Debt

31.1b33.4b25.8b

Total Liabilities

47.6b49.5b40.6b

Additional Paid-in Capital

32.2b29.6b28.1b

Retained Earnings

21.7b23.3b24.4b

Total Equity

52.1b50.3b50.8b

EPS

1.51.72.3

Debt to Equity Ratio

0.6 x0.7 x0.5 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x

Financial Leverage

1.9 x2 x1.8 x

Quarterly

USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Cash

3.1b3.0b2.8b4.7b5.5b6.4b4.4b3.9b3.7b

Accounts Receivable

5.4b5.7b5.5b5.8b5.8b5.8b5.7b5.7b5.9b

Inventories

3.6b3.7b3.7b3.5b3.6b3.8b3.7b3.8b3.9b

Current Assets

23.5b22.5b22.4b24.8b25.2b26.6b22.5b21.7b20.9b

PP&E

4.8b4.9b4.9b4.4b4.4b4.5b4.5b4.5b4.6b

Goodwill

41.3b41.7b41.2b39.2b39.1b39.8b39.0b38.6b40.0b

Total Assets

98.6b98.4b97.6b100.3b94.5b95.8b89.7b88.2b88.7b

Accounts Payable

1.6b1.7b1.6b1.8b1.7b1.8b1.8b1.7b1.7b

Short-term debt

1.9b3.4b6.2b8.1b3.1b2.9b1.5b1.3b1.4b

Current Liabilities

7.9b9.6b12.7b15.1b10.5b10.9b9.1b8.5b8.9b

Long-term debt

30.1b29.0b25.9b26.0b25.9b25.9b23.7b23.7b23.7b

Total Debt

32.1b32.4b32.1b34.0b29.1b28.8b25.2b25.0b25.0b

Total Liabilities

47.7b48.1b48.1b49.5b42.9b45.5b39.4b38.4b38.8b

Additional Paid-in Capital

28.6b28.1b28.2b27.8b27.0b25.8b

Retained Earnings

52.8b52.5b52.3b24.0b25.4b23.4b24.7b25.2b25.8b

Total Equity

50.9b50.3b49.5b50.8b51.6b50.3b50.3b49.7b49.9b

Debt to Equity Ratio

0.6 x0.6 x0.6 x0.7 x0.6 x0.6 x0.5 x0.5 x0.5 x

Debt to Assets Ratio

0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x0.3 x

Financial Leverage

1.9 x2 x2 x2 x1.8 x1.9 x1.8 x1.8 x1.8 x

Medtronic Cash Flow

Annual

USDFY, 2016FY, 2017FY, 2018

Net Income

3.5b4.0b3.1b

Depreciation and Amortization

2.8b2.9b2.6b

Accounts Receivable

(435.0m)(75.0m)(275.0m)

Inventories

(186.0m)(227.0m)(192.0m)

Accounts Payable

(379.0m)356.0m65.0m

Cash From Operating Activities

5.2b6.9b4.7b

Purchases of PP&E

(1.0b)(1.3b)(1.1b)

Cash From Investing Activities

2.2b(1.6b)5.9b

Short-term Borrowings

(132.0m)904.0m(294.0m)

Long-term Borrowings

(5.1b)(863.0m)(7.4b)

Dividends Paid

(2.1b)(2.4b)(2.5b)

Cash From Financing Activities

(9.5b)(3.3b)(12.0b)

Net Change in Cash

(2.0b)2.1b(1.3b)

Interest Paid

1.3b1.1b1.1b

Income Taxes Paid

1.4b1.0b2.5b

Quarterly

USDQ1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019Q3, 2019

Net Income

929.0m2.0b2.9b1.0b3.0b1.6b1.1b2.2b3.5b

Depreciation and Amortization

737.0m1.5b2.2b636.0m1.3b2.0b666.0m1.3b2.0b

Accounts Receivable

196.0m(89.0m)18.0m(88.0m)(68.0m)19.0m138.0m(37.0m)(140.0m)

Inventories

(101.0m)(187.0m)(261.0m)(164.0m)(273.0m)(318.0m)(180.0m)(312.0m)(367.0m)

Accounts Payable

(298.0m)(306.0m)32.0m(392.0m)(307.0m)13.0m85.0m24.0m211.0m

Cash From Operating Activities

1.6b3.0b5.1b737.0m1.6b3.6b1.7b2.9b4.9b

Purchases of PP&E

(330.0m)(598.0m)(924.0m)(278.0m)(524.0m)(776.0m)(291.0m)(497.0m)(799.0m)

Cash From Investing Activities

(284.0m)(357.0m)(1.3b)83.0m6.1b5.7b643.0m764.0m(245.0m)

Short-term Borrowings

926.0m1.2b1.1b569.0m(190.0m)(391.0m)(505.0m)(700.0m)(696.0m)

Long-term Borrowings

(17.0m)(252.0m)(361.0m)(8.0m)(4.2b)(4.2b)(12.0m)(17.0m)(29.0m)

Dividends Paid

(599.0m)(1.2b)(1.8b)(625.0m)(1.2b)(1.9b)(677.0m)(1.4b)(2.0b)

Cash From Financing Activities

(1.2b)(2.7b)(4.0b)(1.1b)(7.3b)(8.1b)(1.6b)(3.3b)(4.6b)

Net Change in Cash

184.0m78.0m(108.0m)(276.0m)562.0m1.4b711.0m242.0m34.0m

Interest Paid

68.0m559.0m626.0m68.0m587.0m651.0m55.0m482.0m540.0m

Income Taxes Paid

115.0m258.0m474.0m417.0m674.0m911.0m348.0m941.0m1.2b

Medtronic Ratios

USDY, 2019

EV/EBIT

87.1 x

EV/CFO

27.3 x

Debt/Equity

0.5 x

Debt/Assets

0.3 x

Financial Leverage

1.8 x

Medtronic Operating Metrics

FY, 2015FY, 2016FY, 2017FY, 2018

Countries

160 160 160 150

Locations

345 224 189 180

Locations (US)

70 12 12 12

Manufacturing Facilities

80 89

Medtronic Human Capital

FY, 2016FY, 2015FY, 2014
Male, percent51 %52 %51 %
Female, percent49 %48 %49 %

Medtronic Employee Rating

3.63271 votes
Culture & Values
3.6
Work/Life Balance
3.4
Senior Management
3.0
Salary & Benefits
3.7
Career Opportunities
3.4
Source